rs2234487

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004738.5(VAPB):​c.315+35C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.414 in 1,041,992 control chromosomes in the GnomAD database, including 92,965 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 14311 hom., cov: 32)
Exomes 𝑓: 0.41 ( 78654 hom. )

Consequence

VAPB
NM_004738.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.731

Publications

14 publications found
Variant links:
Genes affected
VAPB (HGNC:12649): (VAMP associated protein B and C) The protein encoded by this gene is a type IV membrane protein found in plasma and intracellular vesicle membranes. The encoded protein is found as a homodimer and as a heterodimer with VAPA. This protein also can interact with VAMP1 and VAMP2 and may be involved in vesicle trafficking. [provided by RefSeq, Jul 2008]
VAPB Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • adult-onset proximal spinal muscular atrophy, autosomal dominant
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 20-58434740-C-T is Benign according to our data. Variant chr20-58434740-C-T is described in ClinVar as Benign. ClinVar VariationId is 259537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.568 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VAPBNM_004738.5 linkc.315+35C>T intron_variant Intron 3 of 5 ENST00000475243.6 NP_004729.1 O95292-1Q53XM7
VAPBNM_001195677.2 linkc.212-9337C>T intron_variant Intron 2 of 2 NP_001182606.1 O95292-2
VAPBNR_036633.2 linkn.443-6167C>T intron_variant Intron 2 of 3
VAPBXR_001754433.3 linkn.546+35C>T intron_variant Intron 3 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VAPBENST00000475243.6 linkc.315+35C>T intron_variant Intron 3 of 5 1 NM_004738.5 ENSP00000417175.1 O95292-1

Frequencies

GnomAD3 genomes
AF:
0.431
AC:
65360
AN:
151634
Hom.:
14302
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.428
Gnomad AMI
AF:
0.465
Gnomad AMR
AF:
0.367
Gnomad ASJ
AF:
0.419
Gnomad EAS
AF:
0.586
Gnomad SAS
AF:
0.359
Gnomad FIN
AF:
0.549
Gnomad MID
AF:
0.411
Gnomad NFE
AF:
0.423
Gnomad OTH
AF:
0.396
GnomAD2 exomes
AF:
0.413
AC:
99828
AN:
241560
AF XY:
0.416
show subpopulations
Gnomad AFR exome
AF:
0.426
Gnomad AMR exome
AF:
0.302
Gnomad ASJ exome
AF:
0.405
Gnomad EAS exome
AF:
0.572
Gnomad FIN exome
AF:
0.531
Gnomad NFE exome
AF:
0.415
Gnomad OTH exome
AF:
0.402
GnomAD4 exome
AF:
0.411
AC:
365532
AN:
890238
Hom.:
78654
Cov.:
12
AF XY:
0.411
AC XY:
191803
AN XY:
466374
show subpopulations
African (AFR)
AF:
0.420
AC:
9392
AN:
22374
American (AMR)
AF:
0.309
AC:
13484
AN:
43618
Ashkenazi Jewish (ASJ)
AF:
0.410
AC:
9295
AN:
22664
East Asian (EAS)
AF:
0.631
AC:
23234
AN:
36830
South Asian (SAS)
AF:
0.359
AC:
26686
AN:
74306
European-Finnish (FIN)
AF:
0.518
AC:
25469
AN:
49148
Middle Eastern (MID)
AF:
0.409
AC:
1757
AN:
4296
European-Non Finnish (NFE)
AF:
0.402
AC:
239370
AN:
595422
Other (OTH)
AF:
0.405
AC:
16845
AN:
41580
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
9762
19524
29287
39049
48811
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4860
9720
14580
19440
24300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.431
AC:
65409
AN:
151754
Hom.:
14311
Cov.:
32
AF XY:
0.437
AC XY:
32416
AN XY:
74152
show subpopulations
African (AFR)
AF:
0.428
AC:
17705
AN:
41346
American (AMR)
AF:
0.367
AC:
5588
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.419
AC:
1452
AN:
3468
East Asian (EAS)
AF:
0.586
AC:
3033
AN:
5180
South Asian (SAS)
AF:
0.358
AC:
1721
AN:
4806
European-Finnish (FIN)
AF:
0.549
AC:
5764
AN:
10494
Middle Eastern (MID)
AF:
0.425
AC:
125
AN:
294
European-Non Finnish (NFE)
AF:
0.423
AC:
28755
AN:
67912
Other (OTH)
AF:
0.400
AC:
843
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1907
3815
5722
7630
9537
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
618
1236
1854
2472
3090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.428
Hom.:
2676
Bravo
AF:
0.413
Asia WGS
AF:
0.452
AC:
1567
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Amyotrophic lateral sclerosis type 8 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Adult-onset proximal spinal muscular atrophy, autosomal dominant Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
7.4
DANN
Benign
0.73
PhyloP100
0.73
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234487; hg19: chr20-57009796; COSMIC: COSV55666732; COSMIC: COSV55666732; API